Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, Peter G., Kauffman, Carol A., Andes, David, Benjamin, Daniel K., Calandra, Thierry F., Edwards, John E., Filler, Scott G., Fisher, John F. +6 more·2009·Clinical Infectious Diseases

Cited by (1,018)

Items 701–800 of 1,018

  1. Optimizing management of invasive mould diseases
    Sudhir Agrawal, William W. Hope, János Sinkó, Christopher C. Kibbler · 2010 · Journal of Antimicrobial Chemotherapy
  2. Candida parapsilosisand the neonate: epidemiology, virulence and host defense in a unique patient setting
    Brian D. W. Chow, Jennifer R. Linden, Joseph M. Bliss · 2012 · Expert Review of Anti-infective Therapy
  3. Epidemiology and risk factors for nosocomial Non-Candida albicanscandidemia in adult patients at a tertiary care hospital in North China
    Xiurong Ding, Donghui Yan, Wei Sun, Zhaoyin Zeng, Ruirui Su, Jianrong Su · 2015 · Medical Mycology
  4. Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone
    Estelle Cateau, Jean‐Marc Berjeaud, Christine Imbert · 2011 · International Journal of Antimicrobial Agents
  5. Burden of serious fungal infections in Mexico
    Dora Corzo-León, Darius P. H. Armstrong-James, David W. Denning · 2015 · Mycoses
  6. A Phase 2, Randomized, Double-Blind, Multicenter Trial To Evaluate the Safety and Efficacy of Three Dosing Regimens of Isavuconazole Compared with Fluconazole in Patients with Uncomplicated Esophageal Candidiasis
    J. Viljoen, Nkechi E. Azie, Anne-Hortense Schmitt-Hoffmann, Mahmoud Afif Ghannoum · 2015 · Antimicrobial Agents and Chemotherapy
  7. The novel arylamidine T-2307 demonstrates <i>in vitro</i> and <i>in vivo</i> activity against echinocandin-resistant <i>Candida glabrata</i>
    Wiederhold, Nathan P., Najvar, Laura K., Fothergill, Annette W., Bocanegra, Rosie, Olivo, Marcos, McCarthy, Dora I., Fukuda, Yoshiko, Mitsuyama, Junichi, Patterson, Thomas F. · 2016 · Journal of Antimicrobial Chemotherapy
  8. Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to <i>Candida parapsilosis</i> : a retrospective observational cohort study of the Mycoses Study Group (MSG-12): Table 1.
    Chiotos, Kathleen, Vendetti, Neika, Zaoutis, Theoklis E., Baddley, John, Ostrosky-Zeichner, Luis, Pappas, Peter, Fisher, Brian T. · 2016 · Journal of Antimicrobial Chemotherapy
  9. Clinical characteristics and risk factors for mortality in adult patients with persistent candidemia
    Seung‐Ji Kang, Seong Eun Kim, Uh Jin Kim, Hee‐Chang Jang, Kyung‐Hwa Park, Jong Hee Shin, Sook‐In Jung · 2017 · Journal of Infection
  10. Antifungal Extraction by the Extracorporeal Membrane Oxygenation Circuit
    Kevin Watt, Michael Cohen‐Wolkowiez, Duane C. Williams, Desiree K. Bonadonna, Ira M. Cheifetz, Dhiren R. Thakker, Daniel K. Benjamin, Kim L. R. Brouwer · 2017 · Journal of ExtraCorporeal Technology
  11. A prospective, multi-center study of Candida bloodstream infections in Chile
    Marı́a Elena Santolaya, Luis Thompson, Dona Benadof F, Cecilia V. Tapia, Paulette Legarraga, Claudia P. Cortés, Marcela Rabello, Romina Valenzuela, Pamela Rojas, Ricardo Rabagliati B et al. · 2019 · PLoS ONE
  12. Management of Patients With Fever and Neutropenia Through the Arc of Time
    Philip A. Pizzo · 2019 · Annals of Internal Medicine
  13. The incidence of endophthalmitis or macular involvement and the necessity of a routine ophthalmic examination in patients with candidemia
    Takashi Ueda, Yoshio Takesue, Issei Tokimatsu, Taiga Miyazaki, Nana Nakada, Miki Nagao, Kazuhiko Nakajima, Hiroshige Mikamo, Yuka Yamagishi, Kei Kasahara et al. · 2019 · PLoS ONE
  14. Candidemia en Colombia
    Jorge Alberto Cortés, José Franklin Ruiz, Lizeth Natalia Melgarejo Moreno, Elkin V. Lemos · 2020 · Biomédica
  15. Clinical characteristics, risk factors and outcomes of mixed Candida albicans/bacterial bloodstream infections
    Li Zhong, Shufang Zhang, Kankai Tang, Feifei Zhou, Cheng Zheng, Kai Zhang, Jiachang Cai, Hongwei Zhou, Yesong Wang, Baoping Tian et al. · 2020 · BMC Infectious Diseases
  16. Recent Advances in Antifungal Prevention and Treatment
    Andreas H. Groll, Athanasios Tragiannidis · 2009 · Seminars in Hematology
  17. Candida-induced prosthetic joint infection. A literature review including 72 cases and a case report
    Fernando Cobo, Javier Rodríguez‐Granger, Enrique Martínez López, Gemma Jiménez-Guerra, Antonio Sampedro, Luis Aliaga–Martínez, José María Navarro‐Marí · 2016 · Scandinavian Journal of Infectious Diseases
  18. Catheter-associated candiduria: Risk factors, medical interventions, and antifungal susceptibility
    Dan Padawer, Nina Pastukh, Orna Nitzan, Kozitta Labay, Ilana Aharon, Diana Brodsky, Tatyana Glyatman, Avi Peretz · 2015 · American Journal of Infection Control
  19. Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation
    Julien Poissy, Boualem Sendid, Sébastien Damiens, Ken Ichi Ishibashi, Nadine François, Marie Kauv, Raphaël Favory, Daniel Mathieu, Daniel Poulain · 2014 · Critical Care
  20. Candida Colonization in Urine Samples of ICU Patients: Determination of Etiology, Antifungal Susceptibility Testing and Evaluation of Associated Risk Factors
    Nidhi Singla, Neelam Gulati, Neelam Kaistha, Jagdish Chander · 2012 · Mycopathologia
  21. Genotoxic effect of photodynamic therapy mediated by curcumin on Candida albicans
    Juliana Cabrini Carmello, Ana Cláudia Pavarina, Rui Pedro Soares de Oliveira, Björn Johansson · 2015 · FEMS Yeast Research
  22. Novel strategies for the prevention and treatment ofCandidainfections: the potential of immunotherapy
    Frank L. van de Veerdonk, Mihai Gheorghe Netea, Leo A. B. Joosten, Jos W. M. van der Meer, Bart Jan Kullberg · 2010 · FEMS Microbiology Reviews
  23. Prior Caspofungin Exposure in Patients with Hematological Malignancies Is a Risk Factor for Subsequent Fungemia Due to Decreased Susceptibility in Candida spp.: a Case-Control Study in Paris, France
    Élodie Blanchard, Olivier Lortholary, Karine Sitbon, Marie Desnos‐Ollivier, Françoise Dromer, Didier Guillemot, the French Mycosis Study Group · 2011 · Antimicrobial Agents and Chemotherapy
  24. Infections and Extracorporeal Membrane Oxygenation
    Fabian Haneke, Thomas A. Schildhauer, Alexander D. Schlebes, Justus Thomas Strauch, Justyna Swol · 2015 · ASAIO Journal
  25. Invasive candidiasis: from mycobiome to infection, therapy, and prevention
    Leonel Lagunes, Jordi Rello · 2016 · European Journal of Clinical Microbiology & Infectious Diseases
  26. Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study
    Roberto Luzzati, Maria Merelli, Filippo Ansaldi, Chiara Rosin, Anna Maria Azzini, Silvia Cavinato, Pierluigi Brugnaro, Claudio Vedovelli, Anna Maria Cattelan, Marina Busetti et al. · 2016 · Infection
  27. Early-Onset Invasive Candidiasis in Extremely Low Birth Weight Infants: Perinatal Acquisition Predicts Poor Outcome
    Michelle Barton, Alex Shen, Karel O’Brien, Joan L. Robinson, H. Dele Davies, Kim Simpson, Elizabeth V Asztalos, Joanne Marie Langley, Nicole Le Saux, Reginald S. Sauve et al. · 2017 · Clinical Infectious Diseases
  28. Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United Kingdom
    Andrew M. Borman, Julian Muller, Jo Walsh-Quantick, Adrien Székely, Zoe Patterson, Michael D. Palmer, Mark Fraser, Elizabeth M. Johnson · 2019 · Antimicrobial Agents and Chemotherapy
  29. Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000-2007
    Nathalie De Castro, Elodie Mazoyer, Raphaël Porcher, Emmanuel Raffoux, Felipe Suárez, Patricia Ribaud, Olivier Lortholary, J.-M. Molina · 2012 · Clinical Microbiology and Infection
  30. Randomized, Comparative, Double-Blind, Double-Dummy, Multicenter Trial of Miconazole Buccal Tablet and Clotrimazole Troches for the Treatment of Oropharyngeal Candidiasis: Study of Miconazole Lauriad®Efficacy and Safety (SMiLES)
    José A. Vazquez, Lauren L. Patton, Joel Brian Epstein, Padaruth Ramlachan, Ismail Haroon Mitha, Zoja Noveljic, Jan Fourie, Brian Conway, Rajesh V. Lalla, Andrei Barasch et al. · 2010 · HIV Clinical Trials
  31. Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis
    Alfonso Javier Carrillo‐Muñoz, Cristina Tur‐Tur, Gustavo Giusiano, Cristina Marcos‐Arias, Elena Eraso, Nerea Jauregizar, Guillermo Quindós · 2013 · Expert Review of Anti-infective Therapy
  32. Isavuconazole and Nine Comparator Antifungal Susceptibility Profiles for Common and Uncommon Candida Species Collected in 2012: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values
    Mariana Castanheira, Shawn A. Messer, Paul R. Rhomberg, Rachel D. Dietrich, Ronald N. Jones, Michael A. Pfaller · 2014 · Mycopathologia
  33. Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
    Andreas Glöckner · 2011 · European journal of medical research
  34. Comparison of albicans vs. non-albicans candidemia in French intensive care units
    Olivier Leroy, Jean Paul Mira, Philippe Montravers, Jean‐Pierre Gangneux, Olivier Lortholary, the AmarCand Study Group · 2010 · Critical Care
  35. Candida parapsilosis complex water isolates from a haemodialysis unit: biofilm production and in vitro evaluation of the use of clinical antifungals
    Regina Helena Pires, Jaime Maia dos Santos, José Eduardo Zaia, Carlos Henrique Gomes Martins, Maria José Soares Mendes‐Giannini · 2011 · Memórias do Instituto Oswaldo Cruz
  36. The Host’s Reply to Candida Biofilm
    Jeniel E. Nett · 2016 · Pathogens
  37. Fungal Infections of the Spine
    Devin Ganesh, Jonathan Gottlieb, Sherilynn F. Chan, Octavio Martínez, Frank J. Eismont · 2015 · Spine
  38. Identification and Antifungal susceptibility testing of Candida species: A Comparison of Vitek-2 system with conventional and molecular methods
    Ravinder Kaur, Megh Singh Dhakad, Ritu Goyal, Absarul Haque, Gauranga Mukhopadhyay · 2016 · Journal of Global Infectious Diseases
  39. Overexpression of MDR-1 and CDR-2 genes in fluconazole resistance of Candida albicans isolated from patients with vulvovaginal candidiasis
    Kamelia Rad, Mehraban Falahati, Maryam Roudbary, Shirin Farahyar, Sanam Nami · 2016 · Current Medical Mycology
  40. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B
    Daniel Brustolin Ludwig, Luciana Erzinger Alves de Camargo, Najeh Maissar Khalil, Marcos Ereno Auler, Rubiana Mara Mainardes · 2018 · Mycopathologia
  41. A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
    Daniel K. Benjamin, David A Kaufman, William W. Hope, P. Brian Smith, Antonio Carlos Arrieta, Paolo Manzoni, Laura Lynn Kovanda, Christopher Lademacher, Brigit Isaacson, Deborah Jednachowski et al. · 2018 · The Pediatric Infectious Disease Journal
  42. Pharmacokinetics and Pharmacodynamics of Antibacterials, Antifungals, and Antivirals Used Most Frequently in Neonates and Infants
    Jessica K. Roberts, Chris R. Stockmann, Jonathan E. Constance, Justin Stiers, Michael G. Spigarelli, Robert M. Ward, Catherine M.T. Sherwin · 2014 · Clinical Pharmacokinetics
  43. Trends in antifungal use in US hospitals, 2006–12
    Vallabhaneni, Snigdha, Baggs, James, Tsay, Sharon, Srinivasan, Arjun R, Jernigan, John A, Jackson, Brendan R · 2018 · Journal of Antimicrobial Chemotherapy
  44. Susceptibility Test Methods: Yeasts and Filamentous Fungi
    Elizabeth M. Johnson, Maiken Cavling Arendrup · 2015 · ASM Press eBooks
  45. Candida albicansand non-Candida albicansfungemia in an institutional hospital during a decade
    Laurence Parmeland, Mathieu Gazon, Claude Guérin, Laurent Argaud, Jean-Jacques Lehot, Olivier H. Bastien, Bernard Allaouchiche, Mauricette Michallet, Stéphane Picot, Anne‐Lise Bienvenu et al. · 2012 · Medical Mycology
  46. Old and new pathogenicNakaseomycesspecies: epidemiology, biology, identification, pathogenicity and antifungal resistance
    A. Angoulvant, J. Guitard, C. Hennequin · 2015 · FEMS Yeast Research
  47. Problematic Dichotomization of Risk for Intensive Care Unit (ICU)–Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients
    Elliott Geoffrey Playford, Jeffrey Lipman, Michael Jones, Anna F. Lau, Masrura Kabir, Sharon C.‐A. Chen, Deborah J. E. Marriott, Ian Seppelt, Thomas Gottlieb, Winston Cheung et al. · 2016 · Clinical Infectious Diseases
  48. The role of biofilm forming on mortality in patients with candidemia: a study derived from real world data
    Carlo Tascini, Emanuela Sozio, Laura Corte, Francesco Sbrana, Claudio Scarparo, Andrea Ripoli, Giacomo Bertolino, Maria Merelli, Enrico Tagliaferri, Antonio Corcione et al. · 2017 · Scandinavian Journal of Infectious Diseases
  49. Yeast species associated with diseased fish: Occurrence, identification, experimental challenges and antifungal susceptibility testing
    Yasmine Hasanine Tartor, Mohamed Adel Taha, Heba Hassan H. Mahboub, Mona El Ghamery · 2018 · Aquaculture
  50. Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?
    Antonio Vena, Patricia Muñóz, Miriam Mateos-Haro, Jesús Guinea, Alicia Galar, Federico Pea, Ana Álvarez‐Uría, Pilar Escribano, Emilio Bouza · 2020 · Infectious Diseases and Therapy
  51. Epidemiology, risk factors, treatment and outcome of Candida bloodstream infections because of Candida albicans and Candida non‐albicans in two district general hospitals in the United Kingdom
    Nadeem Sajjad Raja · 2020 · International Journal of Clinical Practice
  52. Pga13 in Candida albicans is localized in the cell wall and influences cell surface properties, morphogenesis and virulence
    Samuel Gelis, Piet W. J. de Groot, Luís Castillo, Maria Dolores Moragues, Rafael Sentandreu, María-Micaela Gómez, Eulogio Valentı́n · 2012 · Fungal Genetics and Biology
  53. Microbiological findings of culture‐positive preservation fluid in liver transplantation
    Sylvie Janny, Frédéric Bert, Fédérica Dondero, François Durand, P. Guerrini, Paul Merckx, Marie-Hélène Nicolas-Chanoine, Jacques Belghiti, Jean Mantz, Cathérine Paugam‐Burtz · 2010 · Transplant Infectious Disease
  54. Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy
    Sara Tedeschi, Fabio Tumietto, Maddalena Giannella, Michele Bartoletti, Francesco Cristini, G Cioni, Simone Ambretti, Edoardo Carretto, Vittorio Sambri, Mario Sarti et al. · 2016 · European Journal of Internal Medicine
  55. Invasive fungal infections in Neonatal Intensive Care Units of Southern Italy: a multicentre regional active surveillance (AURORA Project)
    Montagna, Maria Teresa, Lovero, G, De Giglio, O, Iatta, R, Giuseppina Caggiano, Montagna, Maria Teresa, Laforgia N; AURORA Project, Group · 2015 · Journal of preventive medicine and hygiene
  56. Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections
    Yuanming Xing, Lu Chen, Yan Feng, Yan Zhou, Yajing Zhai, Jun Lü · 2017 · BMC Infectious Diseases
  57. Orofacial diseases in solid organ and hematopoietic stem cell transplant recipients
    Stefano Petti, Antonella Polimeni, P. Berloco, Crispian M. Scully · 2012 · Oral Diseases
  58. The Epidemiology of Neonatal and Pediatric Candidemia in England and Wales, 2000–2009
    Clarissa Oeser, Theresa L. Lamagni, Paul Trafford Heath, Mike Sharland, Shamez N Ladhani · 2012 · The Pediatric Infectious Disease Journal
  59. Neonatal Intensive Care Unit Candidemia: Epidemiology, Risk Factors, Outcome, and Critical Review of Published Case Series
    Anastasia Spiliopoulou, Gabriel Dimitriou, Eleni Jelastopulu, Ioannis G. Giannakopoulos, Evangelos D. Anastassiou, Myrto Christofidou · 2011 · Mycopathologia
  60. Dose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal Exposure
    Lisa C. Martial, Roger J. M. Brüggemann, Jeroen A. Schouten, Henk J. van Leeuwen, Arthur R. H. van Zanten, Dylan W. de Lange, Eline W. Muilwijk, Paul E. Verweij, David Marinus Burger, Rob E. Aarnoutse et al. · 2015 · Clinical Pharmacokinetics
  61. Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesianain the control of experimental candidiasis
    Diego Conrado Pereira Rossi, Julian Esteban Muñoz, Danielle D Carvalho, Rodrigo C. Belmonte, Bluma Linkowski Faintuch, Primavera Borelli, Antônio Miranda, Carlos P. Taborda, Sirlei Daffre · 2012 · BMC Microbiology
  62. Epidemiology and Evolution of Fungal Pathogens in Plants and Animals
    Pierre Gladieux, Edmond J. Byrnes, Gabriela Aguileta, Matthew C. Fisher, Joseph Heitman, Tatiana Giraud · 2010 · Elsevier eBooks
  63. <scp>EUCAST</scp> Technical Note on <i>Candida</i> and micafungin, anidulafungin and fluconazole
    Cavling Arendrup, Maiken, Cuenca‐Estrella, Manuel, Lass‐Flörl, Cornelia, Hope, William W., The European Committee on Antimicrobial Susceptibility Testing – Subcommittee on Antifungal Susceptibility Testing (EUCAST‐AFST) · 2014 · Mycoses
  64. A Membrane‐Targeted Photosensitizer Prevents Drug Resistance and Induces Immune Response in Treating Candidiasis
    Mingyu Wu, Xiaoyu Xu, Rui Min Hu, Qingrong Chen, Luojia Chen, Yuncong Yuan, Jie Li, Li Zhou, Shun Feng, Lianrong Wang et al. · 2023 · Advanced Science
  65. Fungal Endocarditis Observed Over an 8-Year Period and a Review of the Literature
    Spinello Antinori, Laurenzia Ferraris, Giovanna Orlando, Loredana Tocalli, D. Ricaboni, Mario Corbellino, Salvatore Sollima, Massimo Galli, Laura Milazzo · 2014 · Mycopathologia
  66. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation
    Raoul Herbrecht, Denis Caillot, Catherine Cordonnier, Anne Auvrignon, Anne Thiébaut, Benoît Brethon, Mauricette Michallet, Nizar Mahlaoui, Yves Bertrand, P Preziosi et al. · 2012 · Journal of Antimicrobial Chemotherapy
  67. Activities of Systemically Administered Echinocandins against In Vivo Mature Candida albicans Biofilms Developed in a Rat Subcutaneous Model
    Soňa Kucharíková, Nidhi Sharma, Isabel Spriet, Johan A. Maertens, Patrick Van Dijck, Katrien Lagrou · 2013 · Antimicrobial Agents and Chemotherapy
  68. Critical care management of the patient with cirrhosis awaiting liver transplant in the intensive care unit
    Jody C. Olson, Constantine Jason Karvellas · 2017 · Liver Transplantation
  69. Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI)
    Elisa Vidal, Carlos Cervera, Elisa Cordero, Carlos Armiñanzas, Jordi Carratalà, José Miguel Cisneros, María Carmen Fariñas, Francisco López‐Medrano, Asunción Moreno, Patricia Muñóz et al. · 2015 · Enfermedades Infecciosas y Microbiología Clínica
  70. Invasive fungal infections in renal transplant recipients.
    Parisa Badiee, Abdolvahab Alborzi · 2011 · PubMed
  71. Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner
    Papp, Csaba, Bohner, Flóra, Kocsis, Katica, Varga, Mónika, Szekeres, András, Bodai, László, Willis, Jesse R., Gabaldón, Toni, Tóth, Renáta, Nosanchuk, Joshua D. et al. · 2020 · mSphere
  72. Candida albicans and Antifungal Peptides
    Camila Guimarães de Freitas, Maria Sueli Soares Felipe · 2023 · Infectious Diseases and Therapy
  73. Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal
    S. Leroux, Andrew J. Ullmann · 2013 · Clinical Microbiology and Infection
  74. Infection in Neutropenic Patients with Cancer
    Eric J. Bow · 2013 · Critical Care Clinics
  75. Amphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy – is there a ‘right’ choice?
    Anna Turkova, Emmanuel Roilides, Mike Sharland · 2011 · Current Opinion in Infectious Diseases
  76. SUSCEPTIBILITY OF Candida spp. ISOLATED FROM BLOOD CULTURES AS EVALUATED USING THE M27-A3 AND NEW M27-S4 APPROVED BREAKPOINTS
    Edileusa Rosa dos Santos, Camila F. Dal Forno, Mari Glei Hernandez Liscano, Thaís Felli Kubiça, Tarcieli Pozzebon Venturini, Francieli Chassot, Janio Morais Santurio, Sydney Hartz Alves · 2014 · Revista do Instituto de Medicina Tropical de São Paulo
  77. Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects
    Hamdi Akan, Vispi Antia, Michal Kouba, János Sinkó, Alina Daniela Tanase, Radovan Vrḫovac, Raoul Herbrecht · 2013 · Journal of Antimicrobial Chemotherapy
  78. Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi
    Josep Guarro · 2011 · Journal of Antimicrobial Chemotherapy
  79. Optimizing Echinocandin Dosing and Susceptibility Breakpoint Determination via In Vivo Pharmacodynamic Evaluation against Candida glabrata with and without fks Mutations
    Alexander J. Lepak, Mariana Castanheira, Daniel J. Diekema, Michael A. Pfaller, David R. Andes · 2012 · Antimicrobial Agents and Chemotherapy
  80. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis
    Masahito Nagashima, Yuka Yamagishi, Hiroshige Mikamo · 2015 · Journal of Infection and Chemotherapy
  81. Potential Microbiological Effects of Higher Dosing of Echinocandins
    William J. Steinbach, Frédéric Lamoth, Praveen R. Juvvadi · 2015 · Clinical Infectious Diseases
  82. Fungal Peritonitis: Underestimated Disease in Critically Ill Patients with Liver Cirrhosis and Spontaneous Peritonitis
    Tobias Lahmer, Andreas Brandl, Sebastian Rasch, Roland Michael Schmid, Wolfgang Huber · 2016 · PLoS ONE
  83. Management of Resistant, Atypical and Culture-negative Periprosthetic Joint Infections after Hip and Knee Arthroplasty
    Alexander S. McLawhorn, Danyal H. Nawabi, Amar S. Ranawat · 2016 · The Open Orthopaedics Journal
  84. Extensive functional redundancy in the regulation of C andida albicans drug resistance and morphogenesis by lysine deacetylases H os2, H da1, R pd3 and R pd31
    Xinliu Li, Nicole Robbins, Teresa R. O’Meara, Leah E. Cowen · 2016 · Molecular Microbiology
  85. Suppression of the pathogenicity of Candida albicans by the quorum-sensing molecules farnesol and tryptophol
    Pantira Singkum, Watcharamat Muangkaew, San Suwanmanee, Potjaman Pumeesat, Thanwa Wongsuk, Natthanej Luplertlop · 2019 · The Journal of General and Applied Microbiology
  86. Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts
    Matteo Bassetti, Antonio Vena, Marco Meroi, Celia Cardozo, Guillermo Cuervo, Daniele Roberto Giacobbe, Miguel Salavert, Paloma Merino, Francesca Gioia, Mario Fernández‐Ruiz et al. · 2020 · Critical Care
  87. Prevention and treatment of invasive fungal diseases in neutropenic patients
    Nikolaos G. Almyroudis, Brahm H. Segal · 2009 · Current Opinion in Infectious Diseases
  88. Antifungal Activities of Different Extracts of Marine Macroalgae Against Dermatophytes and Candida Species
    Élica Amara Cecília Guedes, Maria Anilda dos Santos Araújo, Aryanna Kelly Pinheiro Souza, Larissa Isabela Oliveira de Souza, Lurdiana Dayse de Barros, Fernanda Cristina de Albuquerque Maranhão, Antônio Euzébio Goulart Santana · 2012 · Mycopathologia
  89. Prophylaxis, empirical and preemptive treatment of invasive candidiasis
    Playford, Elliott Geoffrey, Lipman, Jeff, Sorrell, Tania C · 2010 · Current Opinion in Critical Care
  90. Intraocular penetration of intravenous micafungin in inflamed human eyes
    Mochizuki, Kiyofumi, Sawada, Akira, Suemori, Shinsuke, Kawakami, Hideaki, Niwa, Yoshiaki, Kondo, Yuji, Ohkusu, Kiyofumi, Yamada, Noriaki, Ogura, Shinji, Yaguchi, Takashi et al. · 2013 · Antimicrobial Agents and Chemotherapy
  91. Detection of Yeasts in Blood Cultures by the Luminex xTAG Fungal Assay
    Joan-Miquel Balada-Llasat, Heidi LaRue, Kamal K. Kamboj, Lisa Rigali, Debra S. Smith, Keelie Thomas, Preeti Pancholi · 2011 · Journal of Clinical Microbiology
  92. Risk factors of late-onset neonatal sepsis in Taiwan: A matched case-control study
    Yin-Hsiang Kung, Yi-Fan Hsieh, Yi‐Hao Weng, Reyin Lien, Jian Fei Luo, Yuan Wang, Yhu‐Chering Huang, Chyi‐Liang Chen, Chih-Jung Chen · 2013 · Journal of Microbiology Immunology and Infection
  93. An Italian consensus for invasive candidiasis management (ITALIC)
    Luigia Scudeller, Claudio Viscoli, Francesco Menichetti, Valerio Del Bono, Francesco Cristini, Carlo Tascini, Matteo Bassetti, Pierluigi Viale · 2013 · Infection
  94. Performance of two MALDI-TOF MS systems for the identification of yeasts isolated from bloodstream infections and cerebrospinal fluids using a time-saving direct transfer protocol
    Axel G. Hamprecht, Sara Christ, Tanja Oestreicher, Georg Plum, Volkhard A. J. Kempf, Stephan Göttig · 2013 · Medical Microbiology and Immunology
  95. Therapeutic Drug Monitoring and Genotypic Screening in the Clinical Use of Voriconazole
    Brad Moriyama, Sameer S. Kadri, Stacey A. Henning, Robert L. Danner, Thomas J. Walsh, Scott R Penzak · 2015 · Current Fungal Infection Reports
  96. Caspofungin Use in Patients with Invasive Candidiasis Caused by Common Non- albicans Candida Species: Review of the Caspofungin Database
    Arnaldo Lopes Colombo, Angela L. Ngai, Michael R. Bourque, Susan K. Bradshaw, Kim M. Strohmaier, Arlene F. Taylor, Robert J. Lupinacci, Nicholas A. Kartsonis · 2010 · Antimicrobial Agents and Chemotherapy
  97. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model
    Mohamed El-Azizi, Noha Samir Farag, Nancy Misri Khardori · 2015 · Annals of Clinical Microbiology and Antimicrobials
  98. Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection
    Judith A. Anesi, John W. Baddley · 2015 · Infectious Disease Clinics of North America
  99. Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections
    Alexandre Méry, Boualem Sendid, Nadine François, Marjorie Cornu, Julien Poissy, Yann Guérardel, Daniel Poulain · 2016 · Journal of Clinical Microbiology
  100. Echinocandin Resistance in Candida Species: a Review of Recent Developments
    Nathan P. Wiederhold · 2016 · Current Infectious Disease Reports